Combined therapy of telbivudine and pegylated interferon α-2a induced sensory neuropathy:2 case reports
10.3760/cma.j.issn.1006-7876.2009.07.012
- VernacularTitle:替比夫定与聚乙二醇干扰素α-2a联用导致感觉神经病二例
- Author:
Riliang ZHENG
;
Wei ZHANG
;
Yua YUAN
- Publication Type:Journal Article
- Keywords:
Telbivudine;
Polyethylene glycols;
Interferon alfa-2a;
Drug therapy,combination;
Poisoning;
Peripheral nervous system diseases
- From:
Chinese Journal of Neurology
2009;42(7):475-478
- CountryChina
- Language:Chinese
-
Abstract:
Objective To report the clinical and pathological features of the sensory neuropathy caused by a combined therapy of telbivudine and pegylated interferon α-2a in 2 patients with hepatitis B virus infection Methods Two male patients aged 48(case 1)and 20(case 2),who suffered from hepatitis B virus infection.were given telbivudine and pegylated interferon α-2a.After 4 months treatment,both patients developed numbness and pain in the lower limbs.The physical examination showed decreased pain sensation in distal extremities.Hypahidrosis appeared in distal extremities.The nails were pale changed in fingers and toes in cage 1.Case 2 presented mild weakness in the proximal muscle of lower limbs and the tendon reflex was decreased in both lower limbs.His 8erunl creatine kinase level was mild elevated.The electromyography examination and sural nerve biopsies were performed on both patients.Results Electromyography examination showed significant decrease of amplitude of sensory nerve action potentials and mild decrease of sensory nerve conduction velocities in both patients.The amplitude of motor nerve action potentials was also decreased in case 2.Light microscope examination revealed middle reduction of myelinated fibers,wallerian degeneration of myelinated fibers and small clusbers of regenerated fibers in sural nerve.Electro microscopy examination revealed the loss of unmyehnated nerve fibers.After the combined therapy was stopped and vitamin B,CoQ10 and L-camitine were administered,the patients recovered gradually.Conclusions Combined therapy of telbivudine and pegylated interferon α-2a may cause sensory neuropathy with electrophsiological and pathological abnormalities of axonal lesions.The sensory neuropathy induced by the combined therapy may be reversible.
